Skip to content
Trial Agents

Leon Research S.L. Sucursal Em Portugal

Leon Research S.L. Sucursal Em Portugal is recorded as a service provider in 2 clinical trials. Explore its recorded services, study phases and therapeutic areas, with trial-level operational learnings where available.

2distinct trials
4recorded service labels
0trials with learnings

Data snapshot: 2026-10-09 · About the data

Clinical trial experience

Showing 2 of 2 trials · Latest update first

OPUS-2 - Oral S1P1 Receptor ModUlation in SLE: A Phase 3, multicenter, randomized, double-blind, placebo-controlled, parallel-group study to evaluate the efficacy, safety, and tolerability of cenerimod in adult subjects with moderate-to-severe systemic lupus erythematosus (SLE) on top of background therapy

Sponsor Viatris Innovation GmbH

Start (EU)
Latest update
Estimated end

A Phase 3, multicenter, open-label, single-arm, extension study to evaluate the long-term safety and tolerability of cenerimod in adult subjects with moderate-to-severe systemic lupus erythematosus (SLE) on top of background therapy (OPUS OLE)

Sponsor Viatris Innovation GmbH

Start (EU)
Latest update
Estimated end

Questions about this trial experience

What services are recorded for Leon Research S.L. Sucursal Em Portugal?

The 2026-10-09 snapshot links Leon Research S.L. Sucursal Em Portugal to 2 distinct CTIS trials. Recorded services include Clinical monitoring, Contact for contracts with hospitals, investigators, other parties as required, Investigator recruitment, Project management. These are study-specific roles, not a complete or independently verified capability catalogue.

Which therapeutic areas and study phases are recorded for Leon Research S.L. Sucursal Em Portugal?

The most frequently recorded therapeutic areas are Immunology, Rheumatology. Recorded phases include Phase 3. Use the filters to inspect the supporting studies; missing tags are not evidence of absent experience.

In which countries are trials linked to Leon Research S.L. Sucursal Em Portugal conducted?

The linked trials record locations in 9 countries, including Czechia, Germany, Spain, Poland, Portugal. These are trial locations, not confirmed office locations or countries where Leon Research S.L. Sucursal Em Portugal delivered services.

What can this page tell me about Leon Research S.L. Sucursal Em Portugal's trial experience?

Browse 2 distinct trials with recorded roles, sponsor names, available study dates and links to CTIS source records. No trial-level operational findings are recorded in this snapshot. Trial counts and findings do not measure the provider’s performance or establish responsibility for study outcomes.

About this data & company names

One current approved profile per CTIS trial. Services reflect recorded roles, not a complete capability catalogue or a performance ranking. Missing tags mean the information was not recorded. Country tags describe trial locations, not the provider’s service territory.

Start is the reported EU start date; latest update is the CTIS publication date; estimated end is the reported global estimate, which may be in the past. Missing dates are shown as “Not reported”. Operational learnings describe the trial as a whole and do not establish the provider’s responsibility.

Clear service synonyms are grouped; otherwise the source label is retained. Service tags show the recorded roles for each trial. This page groups 1 recorded name variant under Leon Research S.L. Sucursal Em Portugal. Legacy brands remain separate unless explicitly matched in the name registry.

View recorded company names
  • Leon Research S.L. Sucursal Em Portugal

Never miss a new clinical trial insight

We continuously analyze new and updated clinical trial data and publish practical, evidence-led reports for clinical leaders.